Jeremy E. Chojnacki

A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse

Carlo Marchetti, Jeremy E. Chojnacki, Stefano Toldo et al. · Journal of Cardiovascular Pharmacology · 2013 · 257 citations

Medicine, Cardiology, Pharmacology +15

Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse

Stefano Toldo, Carlo Marchetti, Adolfo G Mauro et al. · International Journal of Cardiology · 2016 · 235 citations

Life Sciences, Cardiology, Immunology +16

NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease

Jun Yin, Fanpeng Zhao, Jeremy E. Chojnacki et al. · Molecular Neurobiology · 2017 · 225 citations

Life Sciences, Neurobiology, Neuroscience +14

Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse

Carlo Marchetti, Stefano Toldo, Jeremy E. Chojnacki et al. · Journal of Cardiovascular Pharmacology · 2015 · 159 citations · Full text

Medicine, Cardiology, Pharmacology +17

Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-<i>N</i>-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis

Chunqing Guo, Jacob Fulp, Yuqi Jiang et al. · ACS Chemical Neuroscience · 2017 · 102 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17